Authors:
EISENMAN A
ARMALI Z
RAIKHLINEISENKRAFT B
BENTUR L
BENTUR Y
GURALNIK L
ENAT R
Citation: A. Eisenman et al., NITRIC-OXIDE INHALATION FOR PARAQUAT-INDUCED LUNG INJURY, Journal of toxicology. Clinical toxicology, 36(6), 1998, pp. 575-584
Authors:
ASSY N
PRUZANSKY Y
GAITINI D
HOCHBERG Z
ENAT R
BARUCH Y
Citation: N. Assy et al., CHANGES IN INSULIN-LIKE GROWTH-FACTOR-I RELEASE AFTER GROWTH-HORMONE ADMINISTRATION IN PATIENTS WITH DIFFERENT GRADES OF LIVER-CIRRHOSIS, Hepatology, 28(4), 1998, pp. 889-889
Authors:
ASSY N
SPIRA G
PAIZI M
SHANKAR L
KRAIZER Y
COHEN T
NEUFELD M
DABBAH B
ENAT R
BARUCH Y
Citation: N. Assy et al., EFFECT OF VASCULAR ENDOTHELIAL GROWTH-FACTOR ON HEPATIC REGENERATIVE ACTIVITY FOLLOWING PARTIAL-HEPATECTOMY IN RATS, Hepatology, 28(4), 1998, pp. 1437-1437
Citation: N. Assy et al., PROGNOSTIC VALUE OF GENERATION OF GROWTH HORMONE-STIMULATED INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) AND ITS BINDING PROTEIN-3 IN PATIENTS WITHCOMPENSATED AND DECOMPENSATED LIVER-CIRRHOSIS, Digestive diseases and sciences, 43(6), 1998, pp. 1317-1321
Citation: Y. Baruch et al., SAFETY OF CONVERSION FROM CYCLOSPORINE SANDIMMUNE TO CYCLOSPORINE NEORAL IN STABLE LIVER-TRANSPLANT PATIENTS, Transplantation proceedings, 30(5), 1998, pp. 1852-1853
Citation: N. Assy et al., PROGNOSTIC VALUE OF GENERATION OF GROWTH HORMONE-STIMULATED INSULIN-LIKE GROWTH-FACTOR-I AND ITS BINDING-PROTEIN IN PATIENTS WITH COMPENSATED AND DECOMPENSATED LIVER-CIRRHOSIS, Hepatology, 26(4), 1997, pp. 322-322
Authors:
ASSY N
HOCHBERG Z
AMIT T
SHENORR Z
ENAT R
BARUCH Y
Citation: N. Assy et al., GROWTH HORMONE-STIMULATED INSULIN-LIKE-GROWTH-FACTOR (IGF)-I AND IGF-BINDING PROTEIN-3 IN LIVER-CIRRHOSIS, Journal of hepatology, 27(5), 1997, pp. 796-802
Authors:
ASSY N
BLUMENFELD Z
BERKOVITZ D
NAVE Y
KRAMSKY R
ROSENTHAL E
ENAT R
BARUCH Y
Citation: N. Assy et al., LONG-TERM FOLLOW-UP OF LIVER-TRANSPLANT PATIENTS IN A NONLIVER TRANSPLANTATION CENTER, Transplantation proceedings, 29(6), 1997, pp. 2664-2666
Citation: A. Eisenman et al., REVERSAL OF RENAL SHUTDOWN SECONDARY TO END-STAGE HEART-FAILURE WITH LOW-DOSE VASOPRESSIN, Circulation, 96(11), 1997, pp. 4297-4297
Authors:
BARUCH Y
WEITZMAN E
MARKIEWICZ W
EISENMAN A
EID A
ENAT R
Citation: Y. Baruch et al., ANASARCA AND HYPERTROPHIC CARDIOMYOPATHY IN A LIVER-TRANSPLANT PATIENT ON FK506 - RELIEVED AFTER A SWITCH TO NEORAL, Transplantation proceedings, 28(4), 1996, pp. 2250-2251
Citation: Y. Baruch et al., BASIC FIBROBLAST GROWTH-FACTOR IS HEPATOTROPIC FOR RAT-LIVER IN REGENERATION, Journal of hepatology, 23(3), 1995, pp. 328-332
Citation: Y. Baruch et al., IMMUNOPROPHYLAXIS WITH HEPATITIS-B IMMUNOGLOBULIN AFTER LIVER-TRANSPLANTATION - AN ECONOMICAL APPROACH, Journal of hepatology, 20(1), 1994, pp. 153-154
Citation: A. Gilhar et al., HLA-DR POSITIVE EPIDERMAL LANGERHANS CELLS IN LIVER-CIRRHOSIS AND IMMUNOSUPPRESSED LIVER TRANSPLANTED PATIENTS, Acta dermato-venereologica, 74(2), 1994, pp. 93-94